Susanne J van Veluw Selected Research

Susanne J van Veluw Research Topics

19	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 04/2024 - 03/2016
8	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2020
7	Hemorrhage 05/2024 - 03/2016
5	Cognitive Dysfunction 01/2023 - 11/2015
3	Cerebral Small Vessel Diseases 04/2024 - 11/2015
3	Cerebral Hemorrhage 02/2024 - 04/2020
2	Siderosis 05/2024 - 12/2020
2	Familial Cerebral Amyloid Angiopathy 04/2020 - 01/2018
2	Dementia (Dementias) 10/2018 - 11/2015
1	Disease Progression 02/2024
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2023
1	Gliosis 08/2023
1	Neuroinflammatory Diseases 08/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Brain Injuries (Brain Injury) 01/2023
1	Amyloid Plaque 11/2022
1	Inflammation (Inflammations) 01/2022
1	Rupture 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Necrosis 03/2016
1	Multiple Sclerosis 01/2016

18	Amyloid (Amyloid Fibrils)IBA 05/2024 - 03/2016
6	IronIBA 05/2024 - 03/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
2	FibrinIBA 01/2021 - 01/2019
2	Formaldehyde (Formol)FDA Link 01/2018 - 01/2016
1	Minocycline (Cyclops)FDA LinkGeneric 02/2024
1	AN-1792IBA 01/2022
1	Waste Products (Waste Product)IBA 01/2022
1	CalciumIBA 01/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	aducanumabIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 04/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	A 7 (A-7)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	estropipate (Ogen)FDA LinkGeneric 01/2019
1	florbetapirIBA 01/2018

2	Immunotherapy 03/2024 - 01/2022
2	Therapeutics 01/2021 - 01/2020
1	Activities of Daily Living (ADL) 01/2023
1	Off-Label Use 01/2021